ORPHENADRINE CITRATE Drug Patent Profile
✉ Email this page to a colleague
When do Orphenadrine Citrate patents expire, and what generic alternatives are available?
Orphenadrine Citrate is a drug marketed by Hikma, Rising, Sagent Pharms, Watson Labs, Ascot, Bayshore Pharms Llc, Impax Pharms, Lupin, Sandoz, and Stevens J. and is included in fifteen NDAs.
The generic ingredient in ORPHENADRINE CITRATE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
Summary for ORPHENADRINE CITRATE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 15 |
Finished Product Suppliers / Packagers: | 19 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Patent Applications: | 869 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ORPHENADRINE CITRATE |
DailyMed Link: | ORPHENADRINE CITRATE at DailyMed |
Pharmacology for ORPHENADRINE CITRATE
Drug Class | Muscle Relaxant |
Physiological Effect | Centrally-mediated Muscle Relaxation |
US Patents and Regulatory Information for ORPHENADRINE CITRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 040463-001 | Mar 4, 2003 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bayshore Pharms Llc | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 091158-001 | Jul 27, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | ORPHENADRINE CITRATE | orphenadrine citrate | INJECTABLE;INJECTION | 084779-001 | Mar 15, 1982 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 085046-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |